New Roles for Immunotherapies and Targeted Agents in Small-Cell Lung Cancer

Optimize care of your patients with SCLC by exploring this comprehensive program designed to keep you abreast of the latest treatment strategies, including an interactive module, downloadable slideset, short expert commentaries, and a case-based video module.
Stephen V. Liu, MD
Taofeek K. Owonikoko, MD, PhD

ClinicalThought

Read this commentary to gain expert perspective on the role of immunotherapy for patients with extensive-stage SCLC.

Stephen V. Liu, MD Released: April 4, 2019

Here are my thoughts on a few studies presented at ASCO 2019 with the potential to impact SCLC care in the near future.

Taofeek K. Owonikoko, MD, PhD Released: June 25, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Bristol-Myers Squibb
Genentech

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue